Form 4 for ANAB ANAPTYSBIO, INC
Accepted 2024-01-09 00:00:00 ET · period of report 2024-01-06 · accession 0001209191-24-001279 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-09 | 2024-01-06 | ANAB | LOUMEAU ERIC J | CLO | M - OptEx | $0.00 | +5,545 | 5,545 | New | $0 |
| D | 2024-01-09 | 2024-01-08 | ANAB | LOUMEAU ERIC J | CLO | S - Sale+OE | $21.81 | -2,305 | 3,240 | -42% | -$50.3K |
| D | 2024-01-09 | 2024-01-06 | ANAB | LOUMEAU ERIC J | CLO | M - OptEx | $0.00 | -5,545 | 16.6K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-06 | M | A | 5,545 | $0.00 | 5,545 | D | — | — | (F1) Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. |
| 2 | Common | Common Stock | 2024-01-08 | S | D | 2,305 | $21.81 | 3,240 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2024-01-06 | M | D | 5,545 | $0.00 | 16,635 | D | — · — to — | 5,545 Common Stock | (F1) Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. (F3) The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |